Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
InDex Pharmaceuticals lead drug candidate is cobitolimod – a new type of drug that can help patients back to a normal life. InDex has also developed a platform of patent protected substances, so called DNA based ImmunoModulatory Sequences (DIMS), with the potential to be used in treatment of various immunological diseases.
Mabtech is a Swedish biotech company that was founded in 1986 by scientists at the Department of Immunology, Stockholm University, and is still owned by the same three researchers and friends. Today we are a considerably larger but still dedicated team that shares an enthusiasm for biomedical research and science, particularly in the field of immunology. Our mission is to assist other researchers with high-quality, dependable research tools and expert technical support.
We develop instruments, software and methods for the analysis of molecular interactions. Our instrument family LigandTracer is dedicated to cell-based real-time interaction analysis. The TraceDrawer evaluation software turns data evaluation efficient, both for LigandTracer and for several other instrument platforms on OEM basis.
SINTEF is the largest independent research organisation in Scandinavia. We create value and innovation through knowledge generation and development of technological solutions that are brought into practical use. SINTEF is a broadly based, multidisciplinary research institute with international top-level expertise in technology, medicine and the social sciences.
Umeå Biotech Incubator is Sweden’s only life science incubator established by rebellious scientists. Today we have grown up to become a state of the art biotech incubator offering facilities, know-how and financing. We have been named one of Europe’s top 15 biotech incubators and we are aiming to become the best.